HS-10234

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-10234, covering 2024-12-17 to 2024-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection [Phase 3]